ANI Pharmaceuticals (ANIP)

[Just the facts maam]

Jeff, ANIP has not revised their estimates. Art was projecting at least $200 million in Operating Income but that was when Acthar was generating over $1 billion in revenue. In 2020, Acthar revenue was $767.9 million the decline partly attributed to lower demand due to Covid 19.

Malllinckrodt which is coming out of bankruptcy will be better positioned to compete on price. As a result I was using lower estimates for the market share ANIP will initially capture. It can still become a blockbuster but it will take time.

JMHO